Three May Be Better Than Two: A Proposal for Metformin Addition to PI3K/Akt Inhibitor-antiandrogen Combination in Castration-resistant Prostate Cancer

Prostate cancer is a prevalent malignant disease. Castration-resistant prostate cancer (CRPC) is a poor prognosis form that develops upon resistance to first-line androgen deprivation therapy. Intensive research is ongoing to find efficient therapeutics for this refractory state. Actually, the combi...

Descripción completa

Detalles Bibliográficos
Autor principal: Delma, Mohamed Islam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278999/
https://www.ncbi.nlm.nih.gov/pubmed/30533337
http://dx.doi.org/10.7759/cureus.3403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278999/
https://www.ncbi.nlm.nih.gov/pubmed/30533337
http://dx.doi.org/10.7759/cureus.3403

Ejemplares similares